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Abstract
Introduction: Two thirds of United States adults are overweight or obese, which puts them at higher risk of
developing chronic diseases and of death compared with normal-weight individuals. However, recent studies have
found that overweight and obesity by themselves may be protective in some contexts, such as hospitalization in
an intensive care unit (ICU). Our objective was to determine the relation between body mass index (BMI) and
mortality at 30 days and 1 year after ICU admission.
Methods: We performed a cohort analysis of 16,812 adult patients from MIMIC-II, a large database of ICU patients
at a tertiary care hospital in Boston, Massachusetts. The data were originally collected during the course of clinical
care, and we subsequently extracted our dataset independent of the study outcome.
Results: Compared with normal-weight patients, obese patients had 26% and 43% lower mortality risk at 30 days
and 1 year after ICU admission, respectively (odds ratio (OR), 0.74; 95% confidence interval (CI), 0.64 to 0.86) and
0.57 (95% CI, 0.49 to 0.67)); overweight patients had nearly 20% and 30% lower mortality risk (OR, 0.81; 95% CI, 0.70
to 0.93) and OR, 0.68 (95% CI, 0.59 to 0.79)). Severely obese patients (BMI ≥ 40 kg/m2) did not have a significant
survival advantage at 30 days (OR, 0.94; 95% CI, 0.74 to 1.20), but did have 30% lower mortality risk at 1 year (OR,
0.70 (95% CI, 0.54 to 0.90)). No significant difference in admission acuity or ICU and hospital length of stay was
found across BMI categories.
Conclusion: Our study supports the hypothesis that patients who are overweight or obese have improved survival
both 30 days and 1 year after ICU admission.
Introduction
Two thirds of the U.S. adult population is obese (body
mass index (BMI), ≥ 30 kg/m2) or overweight (BMI, 25 to
< 30 kg/m2) [1]. Obesity is associated with a higher risk of
developing chronic diseases, including diabetes, hyperten-
sion, osteoarthritis, and coronary artery disease (CAD)
compared with normal weight (BMI, 18.5 to < 25 kg/m2),
and epidemiologic studies have found that obese adults
have significantly higher mortality than do those with a
BMI between 20 and 25 kg/m2 [2]. One national study
found that both obesity and underweight were associated
with significantly higher all-cause mortality [3]. However,
obesity might be associated with increased mortality only
in patients who also have a comorbid condition: a follow-
up study by the same group found that only obese patients
with cardiovascular disease (CVD), obesity-related cancer,
diabetes, or kidney disease had higher mortality [4]. In a
separate long-term observational study on the natural pro-
gression of cardiovascular disease, researchers found that
obesity did not increase the risk of organ failure or in-hos-
pital mortality for those that developed organ failure, and
that diabetes was a significant predictor of both, regardless
of weight status [5].
Studies looking directly at the effect of obesity on mor-
tality after admission to the intensive care unit (ICU) had
mixed results. Some investigators found that obese indivi-
duals had higher mortality during critical illness [6-9],
whereas others reported that obesity either had no effect
[10-14] or was protective compared with normal weight
[15-18]. The studies that found obesity protective were
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either small (< 1,000 patients) [16], focused on a subset of
patients in the ICU (for example, surgical ICU patients
[17], patients with acute lung injury who were mechani-
cally ventilated [18]), or excluded nearly half of the poten-
tially large study population because of missing data [15].
Two large meta-analyses also had mixed results. Oliveros
and Villamor [19] reviewed 23 studies and found that
overweight and obesity, but not severe obesity (BMI ≥ 40
kg/m2), were linked to lower ICU or hospital mortality
(they did not separate the studies that reported ICU mor-
tality from those that reported hospital mortality) [19],
whereas Hogue and colleagues [20] reviewed 22 studies
(most of which were included in the meta-analysis of Oli-
veros and Villamor) and found that overweight and obesity
had no effect on ICU mortality but were associated with
lower hospital mortality.
Most of the previous studies looked at ICU and/or in-
hospital mortality, which can be misleading because of
hospital transfer and discharge practices geared toward
improving performance measures (for example, in-hos-
pital mortality rate) [21]. Few studies have addressed the
effect of BMI on mortality associated with critical illness
at or beyond 30 days after the hospitalization. Also,
many did not use the standard World Health Organiza-
tion (WHO) BMI categories [22] or compared outcomes
of obese patients with those of a reference group that
included not only normal-weight patients but also
underweight and/or overweight patients [7-9,11,12,14],
which may have biased the results, as underweight
patients tend to have worse survival than average. Last,
most studies adjusted for only a limited number of obe-
sity-related conditions and other potential confounders.
We used the Multiparameter Intelligent Monitoring in
Intensive Care (MIMIC-II) database [23] to examine the
relation between BMI and mortality 30 days and 1 year
after ICU admission. MIMIC-II contains clinical ICU
data on > 25,000 patients as well as death data for 1
year after hospital discharge. The size, comprehensive
content, and long-term mortality information contained
in this database may provide the means to clarify the
direction of the association between obesity, obesity-
related conditions, and mortality related to ICU
hospitalization.
Methods and materials
The MIMIC-II database, maintained by the Laboratory
for Computational Physiology at the Massachusetts
Institute of Technology (MIT), contains data on patients
hospitalized in an ICU at Beth Israel Deaconess Medical
Center from 2001 to 2008. The database is freely avail-
able, in that any researcher who accepts the data-use
agreement and has completed “protecting human sub-
jects” training can apply for permission to access the
data [24]. We did not need patient consent or ethics
approval, as all of the data are deidentified. All of the
authors completed the “protecting human subjects”
training. We conducted the study under National Insti-
tutes of Health Institutional Review Board exemption
number 4193.
The MIMIC-II data were deidentified according to the
Health Insurance Portability and Accountability Act Priv-
acy Rules [25]. The deidentification process included ran-
dom date shifting that preserved the temporal relation
with a given patient but not across patients. The database
includes basic admission and demographic information
as well as vital signs, laboratory and radiology results,
medications, discharge diagnoses, nursing notes, physi-
cian discharge summaries, and dates of death. MIMIC-II
contains patients from five ICU types: medical (MICU),
surgical (SICU), cardiac (CCU), cardiac surgery recovery
(CSRU), and neonatal (NICU). We used data from ver-
sion 2.5 and 2.6 of MIMIC-II, as each version contained
information not available in the other.
MIMIC-II contains information on 26,576 unique
patients (see Figure 1). The data were originally collected
during the course of clinical care, and we subsequently
extracted our dataset independent of the study outcome.
We excluded the 6,874 nonadults (primarily neonates)
from the analyses. We also excluded 711 patients who
lacked the dummy identifiers needed to link to their clin-
ical data. Of the remaining 18,991, we removed 2,179
(11%) patients who had no weight recorded, for a final
total of 16,812 patients for our final analysis.
We used weight and height values recorded in the ICU,
and, if needed, from echocardiogram reports and reverse-
computed from a combination of body-surface-area and
weight measurements. Of the 16,812 adult patients with









Figure 1 Study cohort selection. Cohort selection and criteria for
exclusion. *The primary analyses did not include the patients
without weight data; a subsequent sensitivity analysis included
those patients based on imputed values for BMI.
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imputed height values for these patients by using the
sample median height for their age and gender plus or
minus a random value based on the sample standard
deviation. BMI was calculated as (weight (in kilograms)/
height (in meters)2). We grouped patients into the four
major WHO BMI categories: < 18.5 kg/m2 (under-
weight), 18.5 to < 25 kg/m2 (normal weight), 25 to < 30
kg/m2 (overweight), and ≥ 30 kg/m2 (obese) [22]. We
also performed a subgroup analysis on the WHO obese
class III patients, defined as having a BMI ≥ 40 kg/m2 or
“severely obese,” because they have an even higher risk of
developing chronic conditions [2] and of all-cause mor-
tality compared with obese patients with a BMI of 30 to
< 40 kg/m2 [26]. Often the severely obese are not studied
as a group because of insufficient sample size, but the
MIMIC-II database gave us the opportunity to study this
group separately.
We used primarily ICD-9 discharge diagnoses to deter-
mine whether patients had obesity-related conditions
including diabetes mellitus, CVD, obesity-related cancer,
kidney disease, and osteoarthritis. We also used informa-
tion about oral diabetes medications to augment the dia-
betes ICD-9 codes. We split CVD into four categories:
CAD, hypertension, stroke, and “other CVD” (that is,
CVD but not CAD, hypertension, or stroke) to isolate the
effects of each. We used the National Cancer Institute
Obesity and Cancer Fact Sheet [27] to define obesity-
related cancers as colon, breast, esophageal, uterine,
ovarian, kidney, and pancreatic cancer.
We calculated the Simplified Acute Physiology Score
(SAPS) [28], a measure of patient acuity for the first 24
hours of the ICU admission, to assess whether patients in
different BMI categories had different levels of disease
severity when they were admitted to the ICU. The SAPS
is based on the worst recorded value for 14 physiological
and laboratory parameters, including age, certain vital
signs, and laboratory results such as specific electrolytes,
hematocrit, and white cell count, during the first 24
hours of the admission. We calculated the SAPS for each
patient from the MIMIC-II data. Ninety-four percent of
patients had data for all 14 SAPS components. Of the
remaining 6%, 3% had a single component missing, and
the remaining 3% had two or more components missing.
For those that had one or more components missing, we
added results for the missing components from 6 hours
before ICU admission, when available, based on the
assumption that if a patient had a laboratory test a few
hours before ICU admission, the test typically would not
be repeated until the next day. After addition of these
values, 95% had complete SAPS data, 3% had one compo-
nent missing, and only 2% had two or more components
missing. For the final analysis, as specified by the SAPS
algorithm, we assumed a normal score for the missing
components.
Although SAPS is a good measure of patient acuity on
admission to the ICU, it does not reflect a patient’s base-
line health status before events that led to hospitalization.
SAPS II, the updated version of SAPS, includes a score to
account for prior health status based on the presence or
absence of the following chronic conditions: blood can-
cers (leukemia, lymphoma, multiple myeloma), metastatic
cancer, and HIV [29]. We did not calculate the entire
SAPS II score because we did not have enough data for
the FiO2 and PaO2 measurements necessary to calculate
SAPS II that were not in the original SAPS. However, we
used ICD-9 codes to determine whether patients had one
of the three chronic conditions specified by SAPS II to
see if a difference in baseline health existed across the
BMI categories.
Statistical methods
Our statistical methods included the following steps,
which are described in further detail later: (a) univariate
analysis to describe the study variables by BMI category
and to estimate crude mortality risk by BMI category
before adjusting for any covariates; (b) multivariable logis-
tic regression analyses to predict mortality risk by BMI
category after adjusting for a large set of covariates; (c)
sensitivity analyses to determine whether our approach
and assumptions about missing data distorted our results;
and (d) Cox proportional hazards models to confirm the
findings of the multivariable logistic regression models.
Univariate analysis
We used univariate analysis to describe study variables by
BMI category and to determine whether each variable was
significantly different across BMI categories. We used the
Jonckheere-Terpstra test for trend for categoric variables
and the ANOVA test for trend for continuous variables.
In addition, we used c2 tests or Fisher Exact tests for cate-
goric variables and t tests for continuous variables to com-
pare each of the underweight, overweight, and obese
categories with the normal-weight group. We constructed
two univariate logistic regression models, with BMI cate-
gory as the predictor: one had 30-day mortality, and the
other had 1-year mortality as the outcome.
Multivariable regression analysis
We chose the covariates described later, based on clinical
knowledge as well as the previously published literature on
obesity and critical illness. We built the multivariable
models by adding groups of covariates that were likely to
be potential confounders to the univariate model one at a
time in the following order: demographics (age, sex, and
race), obesity-related conditions (diabetes, CAD, stroke,
hypertension, other CVD, obesity-related cancers, kidney
disease, and osteoarthritis), type of admission, ICU unit,
SAPS score, ICU interventions and complications (ventila-
tion, transfusion, total parenteral nutrition (TPN), sepsis,
and pulmonary embolism (PE)), smoking status, marital
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status, and health insurance. Variables were removed only
if P > 0.10. Multicollinearity for independent variables was
assessed by using the variance inflation factor (VIF); no
VIF was > 2.
Sensitivity and Cox proportional hazards analyses
We performed several additional analyses to determine
whether our approach and assumptions about missing
data distorted our results. First, we dealt with any potential
bias of using imputed heights for patients with missing
height values by removing these patients and rerunning
the final multivariable regression models without them.
Second, we imputed BMIs for the 2,179 patients without
weight data whom we had excluded from the primary
study population and reran the analysis. We assigned the
normal BMI category to these patients because overall,
they were a healthier group, and adding them to the nor-
mal BMI group was most likely to reverse our conclusions.
Third, we removed the underweight group and reana-
lyzed the final models to see whether the underweight
(high-mortality) patients skewed the results and whether
removing them would reduce the mortality advantage of
obese and overweight patients compared with those with
normal weight. In addition, we did a subgroup analysis of
the severely obese patients as a separate group.
Fourth, we created a comprehensive CVD variable that
combined CAD, hypertension, stroke, and other CVDs to
determine whether collinearity (a statistical modeling issue
in which high correlation among similar predictors tends
to inflate the estimates of risk in the regression model)
affected the results.
Fifth, we did separate analyses to see whether any of the
obesity-related conditions, admission SAPS, or ICU inter-
ventions mediated the relation between BMI category and
mortality risk. We added each potential mediator sequen-
tially to the model to observe the attenuation effect on the
odds ratios for each BMI category. We performed an addi-
tional analysis to see whether certain medications used to
treat obesity-related conditions (b-blockers, statins, and
insulin) were potential confounders in our analysis, based
on a recent article by Iozzo and colleagues [30]. We did
not include oral diabetes medications as a potential con-
founder because those medications, along with ICD-9
codes, were used by us to define patients with diabetes.
Finally, we analyzed each ICU unit separately to see
whether the association between BMI and mortality was
the same across the unit types.
Finally, we repeated the analysis of the final logistic
regression models by using Cox proportional hazards
regression to see whether the results persisted with a
change in the method of analysis.
We used the SAS v9.2 (SAS Institute Inc, Cary, NC,
USA) FREQ, UNIVARIATE, TTEST, and GLM proce-
dures for univariate analysis, the LOGISTIC procedure for
the logistic regression analysis, and the PHREG procedure
for the Cox models. We used R v2.11.1 (R Foundation for
Statistical Computing, Vienna, Austria) to create Kaplan-
Meier curves and calculate the number at risk.
Results
Univariate analysis of demographic and clinical charac-
teristics by BMI category is shown in Tables 1 and 2,
respectively. More than 30% of patients were in each of
the normal, overweight, and obese categories, and
approximately 5% were underweight. Obese patients
were younger and more likely to be married compared
with the normal-weight group (P < 0.001 for each). The
overweight and obese patients were more likely to have
private insurance compared with normal-weight patients
(P < 0.001).
Clinical covariates included hospitalization characteris-
tics, chronic conditions, and crude mortality by BMI
category. Without adjusting for any covariates, patient
obesity was associated with a higher incidence of chronic
health conditions, including diabetes, hypertension, CAD,
and osteoarthritis (P < 0.001), but not with a higher rate
of obesity-related cancers (P = 0.54) compared with nor-
mal-weight patients. The mean SAPS were very similar
across BMI categories, ranging from 12.0 to 12.3. As
might be expected, overweight and obese patients were
more often mechanically ventilated, treated with insulin,
and more likely to develop wound and skin infections as
well as pulmonary embolism (P < 0.001 for each). No sig-
nificant trend was noted for either ICU or hospital length
of stay across BMI categories. The crude in-hospital, 30-
day, and 1-year mortality rates for overweight and obese
patients were significantly lower compared with those of
normal-weight patients (P < 0.001 for each). In general,
although some differences existed between the BMI
groups with respect to various covariates, none of the dif-
ferences seem to be large enough or to be of sufficient
clinical importance to account for the effect of BMI on
mortality.
As part of the univariate analysis, we calculated mortal-
ity rates by BMI within each SAPS category and found
that for the same level of admission acuity (that is, the
same SAPS category), overweight and obese patients gen-
erally had a lower mortality rate compared with those
with normal weight (see Figure 2), and most of these
results were statistically significant (see Table 3). Only in
the highest SAPS category (the sickest patients) was the
mortality of obese patients greater than that of the nor-
mal-weight patients, but this difference was not statisti-
cally significant. We adjusted for SAPS in our final
model.
To account for conditions that might affect acuity that
the SAPS score does not account for, we analyzed the
distribution of 30-day mortality by BMI category and sig-
nificant underlying diseases at admission based on
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comorbid conditions that are part of the SAPS II acuity
score. Results are shown in Table 4. Twenty-five percent
of obese patients with metastatic cancer died within 30
days compared with 36% of normal-weight patients with
metastatic cancer, which is consistent with our hypoth-
esis that obesity is protective.
The univariate logistic regression models estimated
crude mortality risk 30 days and 1 year after ICU admis-
sion by BMI category without adjusting for any covariates.
Both the overweight and obese patients had markedly
lower mortality risk at both 30 days (OR, 0.70; 95% CI,
0.62 to 0.78) and 0.64 (95% CI, 0.57 to 0.72, respectively)
and 1 year (OR, 0.64 (95% CI, 0.59 to 0.70) and 0.58 [95%
CI, 0.53-0.63]) compared with normal-weight patients. In
contrast, underweight patients had significantly higher risk
in both time periods (30 days: OR, 1.54 (95% CI, 1.29 to
1.84); 1 year: OR, 1.87 (95% CI, 1.61 to 2.17)).
Our multivariable regression models revealed relations
between BMI and mortality that were very similar to those
of the univariate regression analyses (see Table 5). Adjust-
ing for age, sex, race, and obesity-related conditions such
as diabetes, CAD, and kidney disease to the multivariable
model did not appreciably change the mortality risk for
any BMI category compared with the univariate regression
analysis. Even after adjusting for all of the clinical covari-
ates in Table 5, our results were remarkably similar to the
univariate risk estimates: the overweight and obese groups
had mortality risks that were 19% and 26% lower at
30 days (OR, 0.81 (95% CI, 0.70 to 0.93) and 0.74 (95% CI,
0.64 to 0.86)) and an additional 13% and 17% lower at 1
year, respectively (OR, 0.68 (95% CI, 0.59 to 0.79) and 0.57
(95% CI, 0.49 to 0.67)) compared with normal-weight
patients. Underweight patients had 40% and 50% higher
mortality risk at 30 days and 1 year (OR, 1.41 (95% CI,
1.13 to 1.76) and 1.51 (95% CI, 1.18 to 1.94)). The Kaplan-
Meier survival curves, shown in Figure 3, clearly show the
same survival advantage for overweight and obese patients
over time (log-rank test, P < 0.001).
As expected, older age and higher admission SAPS were
associated with increased mortality risk in both time peri-
ods (P < 0.05). Racial minorities had a lower risk of mor-
tality; however, each minority group represented < 10% of
Table 1 Univariate analysis of demographic characteristics by body mass index category.
Total Underweight
(BMI < 18.5 kg/
m2)
Normal
(BMI 18.5 to < 25 kg/
m2)
Overweight
(BMI 25 to < 30 kg/
m2)
Obese




n (%) 16,812 786 (4.7) 5,463 (32.5) 5,276 (31.4) 5,287 (31.4)
Age (years), n (%) < 0.001
< 45 2,522 (15.0) 118 (15.0) 905 (16.6) 757 (14.4)b 742 (14.0)b < 0.001
45-65 5,593 (33.3) 219 (27.9) 1,467 (26.9) 1,677 (31.8)b 2,230 (42.2)b < 0.001
65-80 5,393 (32.1) 215 (27.4) 1,673 (30.6) 1,814 (34.4)b 1,691 (32.0) 0.01
80+ 3,304 (19.7) 234 (29.8)b 1,418 (26.0) 1,028 (19.5)b 624 (11.8)b < 0.001




70.6 (53.0, 81.8) 69.4 (51.7, 80.4) 67.2 (53.6, 77.8) 62.3 (51.7, 73.2) < 0.001
Female, n (%) 7,170 (42.7) 443 (56.4) b 2,469 (45.2) 1,901 (36.0)b 2,357 (44.6) < 0.001
Race, n (%) < 0.001
White 11,390 (82.9) 534 (77.3)b 3,667 (81.5) 3,606 (84.3)b 3,583 (83.8)b < 0.001
Black 1,179 (8.6) 71 (10.3)b 355 (7.9) 333 (7.8) 420 (9.8)b 0.02
Hispanic or Latino 430 (3.1) 16 (2.3) 148 (3.3) 144 (3.4) 122 (2.9) 0.58
Asian 322 (2.3) 47 (6.8)b 173 (3.8) 72 (1.7)a 30 (0.7)b < 0.001
Other 424 (3.1) 23 (3.3) 157 (3.5) 121 (2.8) 123 (2.9) 0.09
Marital status, n (%) < 0.001
Married 8,317 (53.7) 271 (38.6)b 2,524 (50.6) 2,819 (57.8)b 2,703 (55.0)b < 0.001
Single/Divorced/
Separated
4,690 (30.3) 278 (39.5)b 1,545 (31.0) 1,359 (27.9)b 1,508 (30.7) 0.02
Widowed 2,479 (16.0) 154 (21.9)b 923 (18.5) 699 (14.3)b 703 (14.3)b < 0.001
Insurance, n (%) < 0.001
Medicare/Medicaidc 8,806 (52.4) 501 (63.7)b 3,091 (56.6) 2,658 (50.4)b 2,556 (48.3)b < 0.001
Private 6,724 (40.0) 231 (29.4)b 1,877 (34.4) 2,221 (42.1)b 2,395 (45.3)b < 0.001
Other 1,282 (7.6) 54 (6.9)b 495 (9.1) 397 (7.5)b 336 (6.4)b < 0.001
BMI, body mass index. aP value for association or trend across BMI categories; bP < 0.05 compared with normal weight. cMedicare/Medicaid are state or federal
programs in the United States that provide insurance for the elderly or patients with low income or significant chronic health conditions.
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the study population, whereas the reference group com-
prised 67%. Patients in the SICU and CCU had a 34% and
24% lower mortality risk, respectively, at 30 days (OR, 0.66
(95% CI, 0.57 to 0.77) and 0.76 (95% CI, 0.63 to 0.92)) and
27% and 38% lower risk at 1 year (OR, 0.73 (95% CI, 0.62
to 0.85) and 0.62 (95% CI, 0.51 to 0.74)) compared with
the MICU patients, and CSRU patients had a markedly
lower risk in both time periods (OR, 0.15 (95% CI, 0.12 to















Admission type, n (%) < 0.001
Elective 2,656 (15.8) 60 (7.6)b 776 (14.2) 888 (16.8)b 932 (17.6)b < 0.001
Emergency 13,342 (79.4) 693 (88.2)b 4,449 (81.4) 4,137 (78.4)b 4,063 (76.9)b < 0.001
Urgent 814 (4.8) 33 (4.2) 238 (4.4) 251 (4.8) 292 (5.5)b 0.004
ICU First Service, n (%) < 0.001
CCU 2,944 (17.5) 95 (12.1)b 889 (16.3) 1,016 (19.3)b 944 (17.9)b < 0.001
CSRU 3,885 (23.1) 78 (9.9)b 1,123 (20.6) 1,395 (26.4)b 1,289 (24.4)b < 0.001
MICU 5,657 (33.7) 399 (50.8)b 1,907 (34.9) 1,566 (29.7)b 1,785 (33.8) < 0.001
SICU 4,326 (25.7) 214 (27.2) 1,544 (28.3) 1,299 (24.6)b 1,269 (24.0)b < 0.001
SAPS,c mean (SD) 12.1 (5.3) 12.3 (5.3) 12.2 (5.4) 12.0 (5.3)b 12.0 (5.3)b 0.87
Smoker, n (%)d 5,647 (33.9) 256 (32.5) 1,752 (32.1) 1,831 (34.7)b 1,808 (34.2) 0.25
Obesity-related conditions
Diabetes 4,334 (25.8) 117 (14.9)b 1,062 (19.4) 1,300 (24.6)b 1,855 (35.1)b < 0.001
Coronary artery disease 6,612 (39.3) 182 (23.2)b 1,962 (35.9) 2,330 (44.2)b 2,138 (40.4)b < 0.001
Stroke 2,014 (12.0) 92 (11.7) 715 (13.1) 643 (12.2) 564 (10.7)b < 0.001
Hypertension 8,647 (51.4) 311 (39.6)b 2,516 (46.1) 2,827 (53.6)b 2,993 (56.6)b < 0.001
Other CVD 10,066 (59.9) 433 (55.1)b 3,257 (59.6) 3,208 (60.8) 3,168 (59.9) 0.16
Obesity-related cancere 384 (2.3) 20 (2.5) 130 (2.4) 115 (2.2) 119 (2.3) 0.54
Kidney disease 4,118 (24.5) 200 (25.5) 1,271 (23.3) 1,234 (23.4) 1,413 (26.7)b < 0.001
Osteoarthritis 280 (1.7) 7 (0.9) 53 (1.0) 92 (1.7)b 128 (2.4)b < 0.001
Other relevant diagnoses, n (%)
Pulmonary embolism 328 (2.0) 16 (2.0) 79 (1.5) 101 (1.9) 132 (2.5)b < 0.001
Sepsis 1,194 (7.1) 73 (9.3)b 369 (6.8) 353 (6.7) 399 (7.6) 0.60
Wound/skin infection 733 (4.4) 26 (3.3) 186 (3.4) 197 (3.7) 324 (6.1)b < 0.001
ICU interventions, n (%)
Dialysis 1,322 (7.9) 56 (7.1) 417 (7.6) 373 (7.1) 476 (9.0)b 0.007
Ventilation 11,201 (66.6) 469 (59.7)b 3,574 (65.4) 3,551 (67.3)b 3,607 (68.2)b < 0.001
Insulin 6,533 (38.9) 194 (24.7)b 1,912 (35.0) 2,198 (41.7)b 2,229 (42.2)b < 0.001
Transfusion 6,157 (36.6) 276 (35.1) 2,035 (37.3) 1,987 (37.7) 1,859 (35.2)b 0.09
TPN 1,059 (6.3) 59 (7.5) 346 (6.3) 320 (6.1) 334 (6.3) 0.56
Length of stay
ICU LOS, median (Q1-Q3) 2.3 (1.2-4.8) 2.3 (1.1-4.4) 2.3 (1.2-4.8) 2.3 (1.2-4.7) 2.3 (1.2-4.9) 0.11
Hospital LOS, median (Q1-Q3) 8 (4-13) 8 (4-14) 8 (5-13) 7 (4-13) 8 (5-14) 0.97
Mortalityf
Hospital mortality, n (%) 2,047 (12.2) 148 (18.8)b 799 (14.6) 551 (10.4)b 549 (10.4)b < 0.001
Mortality 30 days, n (%) 2,339 (13.9) 185 (23.5)b 910 (16.7) 644 (12.2)b 600 (11.4)b < 0.001
Mortality one year, n (%) 4,392 (26.1) 363 (46.2)b 1,720 (31.5) 1,203 (22.8)b 1,106 (20.9)b < 0.001
aP value for association or trend across BMI categories. bP < 0.05 compared with normal weight. cSAPS was calculated without the age component because age
was an independent variable in the analysis. dIf smoker status was unknown, they were treated as “no.” However, trends were the same when looking at those
with data (known status). eObesity-related cancers: breast, colon, uterine, esophageal, pancreatic, ovarian, and kidney. fThe mortality numbers are cumulative
(that is, the 1-year mortality group includes the 30-day mortality group. Likewise, the 30-day mortality group includes most of the patients who died in the
hospital; however, the few patients that died in the hospital after 30 days were not included in the 30-day mortality.
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0.19) and 0.17 (95% CI, 0.13 to 0.21)). The survival advan-
tage for patients in the CSRU is not surprising, given that
patients admitted to the CSRU are preselected for elective
cardiac surgery, whereas those in the MICU are generally
admitted as an emergency with more critical diagnoses.
As expected, high-mortality conditions, including obe-
sity-related cancers, kidney disease, stroke, and sepsis,
were associated with increased mortality risk in both time
periods. Pulmonary embolus was associated with higher
risk at 30 days, and other CVD was associated with higher
risk at 1 year (P < 0.05 for each). Likewise, lower-acuity
conditions, including CAD, hypertension, and osteoarthri-
tis, were associated with lower risk at both 30 days and
1 year (P < 0.05). Interestingly, patients with diabetes had
lower risk at 30 days (OR, 0.82 (95% CI, 0.71 to 0.94)) but
dropped out of the final regression model for 1-year mor-
tality risk.
Sensitivity and Cox proportional hazards analyses
Our results did not change appreciably in any of our sensi-
tivity analyses. When we removed the patients with
imputed heights, the results of the final multivariable
regression model remained consistent with the primary
analysis in which those with imputed heights were
included. We also compared the 2,179 patients without
any weight measurements with the 16,812 included in our
final analysis. Patients without weight data were more
likely to be younger, admitted to the MICU or SICU, have
shorter ICU and hospital stays, and had a lower mortality
rate at both 30 days and 1 year after ICU admission.
Patients without weight data had better outcomes, and for
this reason, we imputed “normal” BMIs for these patients
because this assumption was most likely to reverse the
mortality advantages of overweight and obese patients. We
then reran the final models, and the results did not
change. At 30 days, the overweight and obese patients had
a mortality risk of 0.78 (95% CI, 0.59 to 0.79) and 0.72
(95% CI, 0.62 to 0.82), respectively, compared with 0.81
(95% CI, 0.70 to 0.93) and 0.74 (95% CI, 0.64 to 0.86)
when the patients with missing weights were not included;
at 1 year, the odds ratios for mortality risk were exactly
the same for both the overweight and obese groups,
Figure 2 The 30-day mortality by SAPS category and BMI. Graph illustrating the differences in 30-day mortality based on the admission
SAPS score and BMI category.
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whether or not the patients with the missing weights were
included in the normal-BMI group.
The results of the analyses without the underweight
group did not change the primary results for the nor-
mal, overweight, or obese groups. When examined as a
separate group, the severely obese patients (BMI ≥ 40
kg/m2; n = 1,119) were similar to the obese group as a
whole, in that they were more likely to be younger, have
private insurance, and have a higher incidence of dia-
betes, hypertension, kidney disease, and osteoarthritis
compared with normal-weight patients. In contrast to
the obese group as a whole, the severely obese patients
were more likely to be female and have a slightly longer
median ICU length of stay, and they did not have lower
30-day mortality risk than did normal-weight patients.
However, they still had significantly lower 1-year risk
compared with normal-weight patients (OR, 0.70 (95%
CI, 0.54 to 0.90)). After taking out the severely obese,
the obese group (BMI 30 to < 40 kg/m2) had an addi-
tional 3% to 5% reduction in risk at both time periods.
(See Additional File 1 for detailed results for the severely
obese group.)
To address potential collinearity in the four CVD predic-
tors in our final model, we reran the final model by using a
more comprehensive, composite CVD variable that
included the four separate cardiac variables in addition to
other CVD conditions. This model produced similar
results for mortality risk by BMI category.





































































































































aP < 0.05 compared with normal weight. bWe followed the original SAPS study, which grouped all of the patients with SAPS > 20 in one category, and the
maximum SAPS we observed was 35.

























































aP < 0.05 compared with normal weight.
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When we examined patients in each ICU unit sepa-
rately, the association between BMI category and mortal-
ity at both 30 days and 1 year was directionally the same
within each ICU unit compared with the estimate in the
final model.
We analyzed each obesity-related condition (diabetes,
CAD, stroke, hypertension, other CVD, obesity-related
cancers, kidney disease, and osteoarthritis), admission
SAPS, and ICU intervention (ventilation, transfusion, and
TPN) to see if any of these potential confounders
Table 5 Multivariable logistic regression results for 30-day and one-year mortality risk.
30 days
Odds ratio (95% CI)
1 year
Odds oatio (95% CI)
BMI category (ref, normal weight (18.5 to < 25 kg/m2))
Underweight (< 18.5 kg/m2) 1.41 (1.13, 1.76)b 1.51 (1.18, 1.94)b
Overweight (25 to < 30 kg/m2) 0.81 (0.70, 0.93)b 0.68 (0.59, 0.79)b
Obese (30 to < 40 kg/m2) 0.74 (0.64, 0.86)b 0.57 (0.49, 0.67)b
Age category (ref < 45 years)
45 to < 65 years 2.44 (1.93, 3.07)b 2.56 (2.01, 3.28)b
65 to < 80 years 3.91 (3.08, 4.96)b 4.43 (3.43, 5.72)b
80+ years 8.16 (6.39, 10.43)b 7.51 (5.72, 9.85)b
Female 0.91 (0.81, 1.02) 0.87 (0.77, 0.99)b
Race (ref, White)
Black 0.60 (0.48, 0.75)b 0.69 (0.55, 0.86)b
Hispanic or Latino 0.53 (0.35, 0.81)b 0.48 (0.31, 0.75)b
Asian 0.46 (0.30, 0.69)b 0.89 (0.61, 1.30)
Other 1.15 (0.82, 1.63) 1.21 (0.83, 1.76)
Insurance (ref, CMS)
Private 0.85 (0.74, 0.98)b 0.83 (0.72, 0.95)b
Other 0.91 (0.71, 1.17) 0.63 (0.46, 0.86)b
Smoker a 1.26 (1.11, 1.43)b
Obesity-related conditions
Diabetes 0.82 (0.71, 0.94)b a
Coronary artery disease 0.68 (0.59, 0.78)b 0.65 (0.56, 0.75)b
Stroke 2.15 (1.84, 2.51)b 1.44 (1.21, 1.73)b
Hypertension 0.64 (0.56, 0.72)b 0.58 (0.51, 0.66)b
Other CVD a 1.47 (1.27, 1.69)b
Obesity-related cancerc 1.38 (1.00, 1.92) 1.89 (1.36, 2.62)b
Kidney disease 1.50 (1.32, 1.71)b 1.94 (1.70, 2.21)b
Osteoarthritis 0.28 (0.15, 0.54)b 0.39 (0.23, 0.66)b
Other relevant diagnoses
Sepsis 1.56 (1.32, 1.85)b 1.51 (1.24, 1.82)b
Pulmonary embolism 2.06 (1.47, 2.88)b a
ICU Unit (ref, MICU)
CCU 0.76 (0.63, 0.92)b 0.62 (0.51, 0.74)b
CSRU 0.15 (0.12, 0.19)b 0.17 (0.13, 0.21)b
SICU 0.66 (0.57, 0.77)b 0.73 (0.62, 0.85)b
SAPSd 1.18 (1.16, 1.19)b 1.09 (1.07, 1.10)b
ICU interventions
Ventilation 1.36 (1.17, 1.59)b a
Transfusion 0.74 (0.65, 0.84)b 1.18 (1.04, 1.34)b
TPN 0.85 (0.68, 1.05) a
aDropped out of the final multivariable model. bP < 0.05. cObesity-related cancers: breast, colon, uterine, esophageal, pancreatic, ovarian, and kidney. dSAPS was
calculated without the age component because age was an independent variable in the analysis.
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mediated the relation between BMI category and mortal-
ity risk. The largest effect that any of the obesity-related
conditions had on any of the four BMI categories was
CAD on the underweight BMI group, but this effect was
neither significant nor clinically important (the OR for
mortality risk decreased from 1.64 (95% CI, 1.34 to 2.0)
to 1.53 (95% CI, 1.25 to 1.88) at 30 days and 1.94 (95%
CI, 1.63 to 2.31) to 1.83 (95% CI, 1.54 to 2.18) at 1 year).
Neither the admission SAPS nor the ICU interventions
had any significant effect (0 to 4% attenuation across
BMI categories in both time periods). When we analyzed
b-blockers, statins, and insulin as potential confounders,
we found that they were also not clinically significant,
and adding them to the model resulted in less than 2%
attenuation in both time periods (none of the ORs chan-
ged by > 0.01).
Last, the estimates of risk from the Cox proportional
hazard models were consistent with the final logistic
regression models with both methods using the same
predictors, indicating that the results were robust to
changes in statistical methods.
Discussion
Critically ill patients who were obese or overweight had
markedly lower 30-day and 1-year mortality risk despite
having higher incidences of many comorbidities and
similar admission acuity compared with their normal-
weight counterparts. At 1 year after critical illness, even
severely obese patients had a significant survival benefit.
The protective effect of obesity (termed the “obesity para-
dox”) has also been reported in obese patients with speci-
fic diagnoses, including acute heart failure [31], chronic
kidney disease [32], and HIV/AIDS [33].
Is a physiological explanation known for this apparent
survival advantage of obesity in critical care? Animal stu-
dies have shown that increases in adipocyte size in obe-
sity lead to M1 macrophage accumulation in adipose
tissue, which produce proinflammatory cytokines and are
linked to insulin resistance [34,35]. In contrast, critically
ill patients have a higher percentage of newly formed,
smaller adipocytes compared with healthy controls [36],
and these adipocytes contain large accumulations of
alternatively activated M2 macrophages that produce
Figure 3 Kaplan-Meier curve for 30-day survival by BMI category. Kaplan-Meier curve for survival by BMI category over the first 30-day
period. The numbers represent the number of patients still surviving in each BMI category at the start of each time period. Note: the survival
probability is truncated at 0.6 for display purposes.
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higher levels of a number of antiinflammatory agents that
increase insulin sensitivity and promote wound healing
[37]. Human macrophages have been shown to switch
between the M1 and M2 phenotypes during critical ill-
ness [38], so perhaps one mechanism by which over-
weight and obesity are protective during critical illness
may be a switch from M1 proinflammatory activation to
alternative M2 antiinflammatory activation in the large
population of macrophages that are already present in
their adipose tissue compared with normal-weight
individuals.
Another theory is the protection provided by increased
nutritional reserves during times of illness [16,19].
Although normal-weight individuals have adequate nutri-
tional intake to cover daily metabolic requirements, they
may not have the stores necessary to sustain organ func-
tion during a time of significantly increased metabolic
demand, such as critical illness. A recent study by Alberda
and colleagues [39] focused on the importance of nutri-
tional supplementation for critically ill patients, and they
found that the positive effect of increased nutrition
occurred primarily in under- and normal-weight patients
and a small subset of middle-range obese patients [39].
Others hypothesized that obese patients might be
admitted to the ICU for less-acute illness because of
increased nursing needs and that they fare better because
they are initially less sick [20]; however, in our study, the
initial mean SAPS was strikingly similar across BMI cate-
gories (see Table 2). Furthermore, overweight and obese
patients had lower mortality compared with the normal-
weight patients in almost every SAPS category. The
exception to this was the obese patients in the highest
(SAPS > 20) category, whose mortality rate was similar to
that of the normal-weight patients in that category and
whose prior risk could have overwhelmed the putative
advantage of obesity.
Each of the four ICU types had different patient popu-
lations in terms of acuity, diagnoses, and interventions,
but our results still held when we analyzed the patients
in each ICU unit separately. We found that the direction
of association between BMI category and mortality
remained the same within each ICU category, although
not all were significant, given the smaller sample sizes
when we divided patients by ICU. In other words, despite
the inherent differences between the patients in the
MICU, SICU, CCU, and CSRU, obese and overweight
patients had a lower mortality risk, and underweight
patients had a higher risk compared with normal-weight
patients within each type of ICU as well as across ICUs.
To assess baseline health status before admission, we
determined whether patients had one of the following
diagnoses: HIV, leukemia/lymphoma/multiple myeloma,
and metastatic cancer. The blood disorders and metastatic
cancer diagnoses were fairly evenly distributed across the
normal, overweight, and obese patients, which was consis-
tent with the distribution of our overall study population.
Far fewer overweight and obese patients had HIV com-
pared with normal weight, but HIV patients composed
only 1% of our study population. A significantly smaller
percentage of obese patients with metastatic cancer died
within 30 days compared with normal-weight patients
with metastatic cancer, which supports the protective
effect we hypothesize. The results for HIV and leukemia/
lymphoma do not show the same relation and were not
statistically significant; however, the number of patients
having these diseases was also small, with little power to
show significant differences.
As others have noted [20], we found that obese patients
admitted to the ICU tended to be younger compared
with normal and underweight patients. We also found
that obese and overweight patients made up most (68%)
of those covered by private insurance rather than Medi-
care or Medicaid, which are state or federal programs in
the United States that provide insurance for the elderly
or patients with low income or significant chronic health
conditions. Both the age and insurance differences could
reflect intrinsic differences in the general health or access
to healthcare and might explain our results; however, the
survival advantage of obesity and overweight compared
with normal weight persisted when we controlled for age
and type of insurance in our multivariable models.
As discussed previously, many of the prior studies did
not compare outcomes based on the standard WHO
categories. Critically ill underweight patients are known
to have higher mortality [3,40,41] compared with nor-
mal-weight patients. The studies that combined the
underweight patients with the normal-weight patients
[9,14] may have masked the true relation between mor-
tality and BMI category. Results from those studies that
compared obese patients with a single group that
included normal, underweight, and overweight patients
[7,8,11,12] are even more difficult to interpret. Further-
more, that bias could have carried over to the results of
both meta-analyses, which were based on several of these
same studies. Our investigation clearly separated the
underweight, normal-weight, overweight, and obese
patients into the standard WHO BMI categories, and the
BMI distribution of our study population generally
reflects that of the general adult U.S. population [1]. In
addition, the mortality advantage of overweight and obe-
sity persisted even when we excluded the underweight
patients from our analysis entirely, and severely obese
patients by themselves also had a significant advantage at
1 year compared with normal-weight patients.
Height measurements were missing for 25% of the
adults with weight values in the MIMIC-II database. In
the ICU setting, measuring height, which requires
patients to stand, can be impossible, given the patient’s
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critical state and likely connection to tubes and ventila-
tors. In addition, patients admitted for observation for
short periods may not have heights measured because
their height value may not be relevant to their ICU stay.
We chose to include the patients lacking height measure-
ments by assigning them imputed height values. Other
studies have lacked greater proportions of such data but
simply excluded them [15]. We checked for potential
bias by removing the patients with imputed heights and
running the model again, and we found no important dif-
ferences in the effect of obesity on survival.
For the 11% of adult patients in MIMIC-II that were
missing values for body weight, we took a different
approach and excluded them from the primary model.
We did this because population weights vary more than
population heights, which makes imputation less reliable,
and the total number missing was much smaller. Patients
without weights were significantly younger, had shorter
lengths of stay, and a lower ICU mortality rate. To be
sure that the exclusion of patients who were missing
weights did not distort our conclusions, in a subsequent
sensitivity analysis, we included these patients in the nor-
mal-BMI category, because putting the patients with
good survival into the normal-weight group was most
likely to change our conclusions. But, as detailed in the
Results, the outcome was almost exactly the same
whether or not they were included and continued to sup-
port the protective effect of obesity.
For patients in the highest SAPS category (> 20), the
mortality rate was much higher compared with that of
patients in the second-highest SAPS category (19-20),
and no significant differences in mortality were found
between BMI groups. This finding suggests that the
advantage of overweight and obesity might be attenuated
for the most critically ill patients. This observation might
be relevant in countries where ICU beds are reserved for
more critical patients than in the United States. For
example, a recent study compared ICU care in the United
States and the United Kingdom and found that the
admission APACHE score was significantly higher in the
U.K. versus the U.S. [42]. The higher acuity score in the
U.K. was a reflection of ICU-bed availability: one seventh
of the number of ICU beds per capita are available in the
U.K. compared with the U.S., so only the sickest patients
are admitted to the ICU.
MIMIC-II offered many advantages for our analysis,
including large sample size, a variety of admission types
and diagnoses, and long-term death data. However, our
study shares the disadvantages of most retrospective stu-
dies, including missing data issues [43], lack of randomi-
zation, and a potential for model misspecification. The
most important missing data element in our study was
patient height, but as described earlier, the sensitivity
analysis showed that including the patients with imputed
heights did not change the results. Regarding study
design, as one cannot randomize patients to BMI cate-
gories, only observational studies of BMI and mortality
are possible, so we have to adjust for confounding
through other means, such as regression. With regard to
mis-specification, although it is possible to exclude inad-
vertently an important confounder from a statistical
model, we chose a comprehensive set of variables based
on clinical experience as well as the current literature,
and MIMIC-II contained all of the variables we wished to
include in the model.
A common issue across clinical databases is underre-
porting of patient diagnoses by using ICD-9 billing codes.
Most of our comorbidity data were drawn from the bill-
ing table, and underreporting of nonacute comorbid con-
ditions may have occurred because they are not the focus
of a hospitalization and/or they do not contribute to
reimbursed diagnosis-related group codes (DRG). This
may explain the “protective” odds ratios we found for
diabetes, CAD, hypertension, and osteoarthritis.
Finally, we would have liked to comment on changes
in the obesity rate and trends in ICU care over time,
but we were unable to do so because of the random
date shifting that MIMIC-II used as part of its deidenti-
fication process.
Conclusions
Our study found that overweight and obese patients have
a much lower mortality risk after ICU admission.
Although the exact mechanism of the association is not
known, we performed extensive analyses to assure that
our findings were not due to confounding factors or
other biases. Two potential remaining explanations are
the benefits of adipose tissue in terms of (a) alternative
macrophage activation and beneficial antiinflammatory
agents, and (b) greater nutritional reserves. We found
that even after adjusting for multiple potential risk fac-
tors, including age, acuity, obesity-related diseases, and
hospital interventions, overweight and obesity still had a
substantial beneficial effect on survival for at least 1 year
after ICU admission.
Key messages
• Overweight and obese patients have significantly lower
mortality both 30 days and 1 year after ICU admission.
• The “protective effect” of overweight and obesity
holds true after adjusting for multiple factors, including
demographics, admission SAPS score, ICU unit, obesity-
related conditions, and various ICU interventions.
• Alternatively activated macrophages may play a role
in lowering mortality risk after an ICU admission for
overweight and obese patients.
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Additional material
Additional file 1: Univariate analysis tables with the severely obese
patients as a separate group. Additional file 1 includes four tables with
results of the univariate analyses after splitting the severely obese
patients (body mass index, ≥ 40 kg/m2) from the rest of the obese
patients (body mass index, 30 to < 40 kg/m2). Table S1 is the univariate
analysis of demographic characteristics. Table S2 is the univariate analysis
of hospitalization characteristics, chronic conditions, and mortality. Table
S3 is the univariate analysis of the initial SAPS distribution and 30-day
mortality. Table S4 is the univariate analysis of the distribution and 30-
day mortality of significant underlying illnesses.
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